Akari Therapeutics (AKTX) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -86.76% |
| Dec 31, 2019 | -75.46% |
| Sep 30, 2019 | -72.00% |
| Jun 30, 2019 | -68.85% |
| Mar 31, 2019 | -66.56% |
| Dec 31, 2018 | -63.46% |
| Sep 30, 2018 | -53.66% |
| Jun 30, 2018 | -47.85% |
| Mar 31, 2018 | -12.15% |
| Dec 31, 2017 | -4.23% |
| Sep 30, 2017 | 5.00% |
| Jun 30, 2017 | 4.17% |
| Mar 31, 2017 | -27.91% |
| Dec 31, 2016 | 44.06% |
| Sep 30, 2016 | 76.23% |
| Jun 30, 2016 | 78.09% |
| Mar 31, 2016 | 69.90% |